Source - SMW
Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1900p (from 1800p).



Broker Forecasts data provided by www.sharesmagazine.co.uk